Search results
Results From The WOW.Com Content Network
GW and Otsuka have now commenced the Phase III development of nabiximols in cancer pain. In December 2012, Sativex was approved in Poland. [15] In 2013, France legalized the use of cannabinoids in medicine, Sativex is the first one to be sold under prescription. [16]
Prescription immediate release (Niacor) and extended release (Niaspan) nicotinic acid are contraindicated for people with either active or a history of liver disease because both, but especially Niaspan, have been associated with instances of serious, on occasion fatal, liver failure.
For prescription medications, the insert is technical, providing information for medical professionals about how to prescribe the drug. Package inserts for prescription drugs often include a separate document called a "patient package insert" with information written in plain language intended for the end-user —the person who will take the ...
CNN reports that overall cancer cases among men will go up 84%, “from 10.3 million in 2022 to 19 million in 2050,” and deaths from cancer are expected to increase 93%, “from 5.4 million in ...
The expanded use of colesevelam in adults with type 2 diabetes mellitus is an example of drug repositioning. [citation needed] Colesevelam is one of the bile-acid sequestrants, which along with niacin and the statins, are the three main types of cholesterol-lowering agents. The statins are considered the first-line agents.
The Beers Criteria are intended to serve as a guide for clinicians and not as a substitute for professional judgment in prescribing decisions. The criteria may be used in conjunction with other information to guide clinicians about safe prescribing in older adults. [5] [non-primary source needed] [6] [non-primary source needed].
emergency medical treatment (including prescription medications) medical evacuations. hospital stays. and surgeries. If you’re vacationing outside the U.S., study your travel insurance options ...
Niacin/simvastatin (trade name Simcor, by Abbott) is a combination drug consisting of an extended release form of the lipid-lowering drug niacin and the statin drug simvastatin. [1]